Wordt geladen...
Targeting the PI3K signaling pathway in cancer
The PI3K pathway is activated in a variety of different human cancers, and inhibitors of this pathway are under active development as anti-cancer therapeutics. In this review, we discuss the data supporting the use of PI3K pathway inhibitors in genetically and clinically defined cancers. This review...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2822054/ https://ncbi.nlm.nih.gov/pubmed/20006486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gde.2009.11.002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|